Of note, 75% of prostate cancer patients with reduced PTEN protein lack a corresponding reduction in mRNA, emphasizing that PTEN protein decay mechanisms may have a broader context within human cancers (Chen et al, 2011). The gene discussed is PTEN; the disease is prostate cancer.